Proteomic study of pilocytic astrocytoma pediatric brain tumor intracystic fluid

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4594-4606

  Inserra, Ilaria ^a   Iavarone, Federica ^a   Martelli, Claudia ^a   Dangelo, Luca ^a,b   Delfino, Daniela ^a   Rossetti, Diana Valeria ^a   Tamburrini, Gianpiero ^b   Massimi, Luca ^b   Caldarelli, Massimo ^b   Di Rocco, Concezio ^b   Messana, Irene ^c   Castagnola, Massimo ^a,d   Desiderio, Claudia ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d CNR   (Italy)

Author keywords

brain tumors; intracystic fluid; mass spectrometry; proteomics; pylocitic astrocytoma

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN D; BETA 2 MICROGLOBULIN; BETA THYMOSIN; CLUSTERIN; COMPLEMENT C3F; CYSTATIN C; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; PROTEIN; THYMOSIN BETA10; THYMOSIN BETA4; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DISULFIDE BOND; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PILOCYTIC ASTROCYTOMA; PROTEIN ANALYSIS; PROTEOMICS; ASTROCYTOMA; CHILD; CYST FLUID; HUMAN; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

ASTROCYTOMA; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYST FLUID; CYSTATIN C; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 84908876757     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500806k     Document Type: Article

References (44)

1. Fleming, A. J.; Chi, S. N. Brain tumors in children Curr. Probl. Pediatr. Adolesc. Health Care 2012, 42, 80-103
2. Hunter, S.; Young, A.; Olson, J.; Brat, D. J.; Bowers, G.; Wilcox, J. N.; Jaye, D.; Mendrinos, S.; Neish, A. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms J. Neuropathol. Exp. Neurol. 2002, 61, 275-281
3. Ohnishi, M.; Matsumoto, T.; Nakasho, R.; Kageyama, T.; Utsuki, S.; Oka, H.; Okayasu, S.; Sato, Y. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein Pathol. Int. 2009, 59, 797-803
4. Khwaja, F. W.; Reed, M. S.; Olson, J. J.; Schmotzer, B.; Gillespie, G. Y.; Guha, A.; Groves, M. D.; Kesary, S.; Pohl, J.; Van Meir, E. G. Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients J. Proteome Res. 2007, 6, 559-570
5. Anagnostopoulos, A. K.; Dimas, K. S.; Papathanassiou, C.; Braoudaki, M.; Anastasiadou, E.; Vougas, K.; Karamolegou, K.; Kontos, H.; Prodromou, N.; Tzortzatou-Stathopoulou, F.; Tsangaris, G. T. Proteomics studies of childhood pilocytic astrocytoma J. Proteome Res. 2011, 10, 2555-2565
6. Esparza-Garrido, R. R.; Velazques-Flores, M. A.; Diegopèrez-RamÍrez, J.; López-Aguilar, E.; Siordia-Reyes, G.; Hernández-Ortiz, M.; MartÍnez-Batallar, á. G.; Encarnación-Guevara, S.; Salamanca-Gómez, F.; Arenas-Aranda, D. J. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight J. Proteomics 2013, 94, 162-175
7. Fang, X.; Wang, C.; Balgley, B. M.; Zhao, K.; Wang, W.; He, F.; Weil, R. J.; Lee, C. S. Targeted tissue proteomic analysis of human astrocytomas J. Proteome Res. 2012, 11, 3937-3946
8. Desiderio, C.; DAngelo, L.; Rossetti, D. V.; Iavarone, F.; Giardina, B.; Castagnola, M.; Massimi, L.; Tamburrini, G.; Di Rocco, C. Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV-and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors Proteomics 2012, 12, 2158-66
9. Pettorini, B. L.; Inzitari, R.; Massimi, L.; Tamburrini, G.; Caldarelli, M.; Fanali, C.; Cabras, T.; Messana, I.; Castagnola, M.; Di Rocco, C. The role of inflammation in the genesis of the cystic component of craniopharyngiomas Child's Nerv. Syst. 2010, 26, 1779-1784
10. Desiderio, C.; Martelli, C.; Rossetti, D. V.; Di Rocco, C.; DAngelo, L.; Caldarelli, M.; Tamburrini, G.; Iavarone, F.; Castagnola, M.; Messana, I.; Cabras, T.; Faa, G. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid Childs Nerv. Syst. 2013, 29, 951-960
11. Martelli, C.; Iavarone, F.; Vincenzoni, F.; Rossetti, D. V.; DAngelo, L.; Tamburrini, G.; Caldarelli, M.; Di Rocco, C.; Messana, I.; Castagnola, M.; Desiderio, C. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches Electrophoresis 2014, 35, 2172-2183
12. Theodorescu, D.; Wittke, S.; Ross, M. M.; Walden, M.; Conaway, M.; Just, I.; Mischak, H.; Frierson, H. F. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis Lancet Oncol. 2006, 7, 230-240
13. Ebert, M. P. A.; Niemeyer, D.; Deininger, S. O.; Wex, T.; Knippig, C.; Hoffmann, J.; Sauer, J.; Albrecht, W.; Malfertheiner, P.; Röcken, C. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry J. Proteome Res. 2006, 5, 2152-2158
14. Zhang, M. H.; Xu, X. H.; Wang, Y.; Ling, Q. X.; Bi, Y. T.; Miao, X. J.; Ye, C. F.; Gao, S. X.; Gong, C. Y.; Xiang, H.; Dong, M. S. A prognostic biomarker for gastric cancer with lymph node metastases Anat. Rec. 2013, 296, 590-594
15. Orvisky, E.; Drake, S. K.; Martin, B. M.; Abdel-Hamid, M.; Ressom, H. W.; Varghese, R. S.; Saha, D.; An, Y.; Hortin, G. L.; Loffredo, C. A.; Goldman, R. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma Proteomics 2006, 6, 2895-2902
16. Ogata, Y.; Hepplmann, C. J.; Charlesworth, M. C.; Madden, B. J.; Miller, M. N.; Kalli, K. R.; Cilby, W. A.; Bergen, H. R., III; Saggese, D. A.; Muddiman, D. C. Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients J. Proteome Res. 2006, 5, 3318-3325
17. Villanueva, J.; Martorella, A. J.; Lawlor, K.; Philip, J.; Fleisher, M.; Robbins, R. J.; Tempst, P. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age Mol. Cell. Proteomics 2006, 5, 1840-1852
18. Karczmarski, J.; Rubel, T.; Mikula, M.; Wolski, J.; Rutkowski, A.; Zagorowicz, E.; Dadlez, M.; Ostrowski, J. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers Acta Biochim. Polym. 2013, 60, 417-425
19. Ganu, V. S.; Müller-Eberhard, H. J.; Hugli, T. E. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized Mol. Immunol. 1989, 26, 939-948
20. Profumo, A.; Mangerini, R.; Rubagotti, A.; Romano, P.; Damonte, G.; Guglielmini, P.; Facchiano, A.; Ferri, F.; Ricci, F.; Rocco, M.; Boccardo, F. Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast J. Proteomics 2013, 85, 44-52
21. Villanueva, J.; Shaffer, D. R.; Philip, J.; Chaparro, C. A.; Erdjument-Bromage, H.; Olshen, A. B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; Sanchez-Carbayo, M.; Holland, E. C.; Cordon-Cardo, C.; Scher, H. I.; Tempst, P. Differential exoprotease activities confer tumor-specific serum peptidome patterns J. Clin. Invest. 2006, 116, 271-284
22. Zhu, D.; Wang, J.; Ren, L.; Yan, L.; Xu, B.; Wei, Y.; Zhong, Y.; Yu, X.; Zhai, S.; Xu, J.; Qin, X. Serum proteomic profiling for the early diagnosis of colorectal cancer J. Cell. Biochem. 2013, 114, 448-455
23. An, Y.; Bekesova, S.; Edwards, N.; Goldman, R. Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma Dis. Markers 2010, 29, 11-20
24. Liang, T.; Wang, N.; Li, W.; Li, A.; Wang, J.; Cui, J.; Liu, N.; Li, Y.; Li, L.; Yang, G.; Du, Z. H.; Li, D.; He, K.; Wang, G. Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessment Proteomics 2010, 10, 90-98
25. Sosne, G.; Qiu, P.; Goldstein, A. L.; Wheater, M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences FASEB J. 2010, 24, 2144-2151
26. Huff, T.; Müller, C. S. G.; Otto, A. M.; Netzker, R.; Hannappel, E. beta-Thymosins, small acidic peptides with multiple functions Int. J. Biochem. Cell Biol. 2001, 33, 205-220
27. Cha, H. J.; Jeong, M. J.; Kleinman, H. K. Role of thymosin beta4 in tumor metastasis and angiogenesis J. Natl. Cancer Inst. 2003, 95, 1674-1680
28. Srinenja, S.; Li, M.; Wongkham, S.; Wongkham, C.; Yao, Q.; Chen, C. Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions Cancer Invest. 2009, 27, 1016-1022
29. Cabras, T.; Pisano, E.; Montaldo, C.; Giuca, M. R.; Iavarone, F.; Zampino, G.; Castagnola, M.; Messana, I. Significant modifications of the salivary proteome potentially associated with complications of Down syndrome revealed by top-down proteomics Mol. Cell. Proteomics 2013, 12, 1844-1852
30. Leung-Tack, J.; Tavera, C.; Gensac, M. C.; Martinez, J.; Colle, A. Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg Exp. Cell Res. 1990, 188, 16-22
31. Tonelle, C.; Colle, A.; Fougereau, M.; Manuel, Y. Partial amino acid sequence of two forms of human post-gamma-globulin. Biochem Biophys. Res. Commun. 1979, 86, 613-619
32. Leung-Tack, J.; Tavera, C.; Gensac, M. C.; Martinez, J.; Colle, A. Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases Inflammation 1990, 14, 247-258
33. Svatoňová, J.; Bořeká, K.; Adam, P.; Lánská, V. Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study Dis. Markers 2014, 2014, 495402
34. Elliott, D. A.; Weickert, C. S.; Garner, B. Apolipoproteins in the brain: implications for neurological and psychiatric disorders Clin. Lipidol. 2010, 51, 555-573
35. Liu, Y.; Sigawa, K.; Sunaga, M.; Umemura, H.; Satoh, M.; Kazami, T.; Yoshikawa, M.; Tomonaga, T.; Yokosuka, O.; Nomura, F. Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry Am. J. Clin. Pathol. 2014, 141, 52-61
36. Chen, Y. T.; Chen, C. L.; Chen, H. W.; Chung, T.; Wu, C. C.; Chen, C. D.; Hsu, C. W.; Chen, M. C.; Tsui, K. H.; Chang, P. L.; Chang, Y. S.; Yu, J. S. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology J. Proteome Res. 2010, 9, 5803-5815
37. de Bont, J. M.; den Boer, M. L.; Reddingius, R. E.; Jansen, J.; Passier, M.; van Schaik, R. H.; Kros, J. M.; Sillevis Smitt, P. A.; Luider, T. H.; Pieters, R. Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling Clin. Chem. 2006, 52, 1501-1509
38. Malik, G.; Ward, M. D.; Gupta, S. K.; Trosset, M. W.; Grizzle, W. E.; Adam, B. L.; Diaz, J. I.; Semmes, O. J. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer Clin. Cancer Res. 2005, 11, 1073-1085
39. Takano, S.; Yoshitomi, H.; Togawa, A.; Sogawa, K.; Shida, T.; Kimura, F.; Shimizu, H.; Tomonaga, T.; Nomura, F.; Miyazaki, M. Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells Oncogene 2008, 27, 2810-2822
40. Xue, A.; Chang, J. W.; Chung, L.; Samra, J.; Hugh, T.; Gill, A.; Butturini, G.; Baxter, R. C.; Smith, R. C. Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma Br. J. Cancer 2012, 107, 1883-1891
41. Harima, Y.; Ikeda, K.; Utsunomiya, K.; Komemushi, A.; Kanno, S.; Shiga, T.; Tanigawa, N. Apolipoprotein C-II is a potential serum biomarker as a prognostic factor of locally advanced cervical cancer after chemoradiation therapy Int. J. Radiat. Oncol. Biol. Phys. 2013, 87, 1155-1161
42. Nicolardi, S.; van der Burgt, Y. E.; Wuhrer, M.; Deelder, A. M. Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles Proteomics 2013, 13, 992-1001
43. Harvey, S. B.; Zhan, Y.; Grady, J. W.; Monkkonen, T.; Nelsestuen, G. L.; Kasthuri, R. S.; Verneris, M. R.; Lund, T. C.; Ely, E. W.; Bernard, G. R.; Zeisler, H.; Homoncik, M.; Jilma, B.; Swan, T.; Kellogg, T. A. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease J. Proteome Res. 2009, 8, 603-612
44. Hunter, S. B.; Varma, V.; Shehata, B.; Nolen, J. D. L.; Cohen, C.; Olson, J. J.; Ou, C. Y. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue J. Histochem. Cytochem. 2005, 53, 963-969